Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 3
2009 1
2011 1
2012 1
2013 3
2014 2
2015 1
2016 1
2018 1
2019 2
2020 1
2021 7
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G Jr, Psyrri A, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Hong RL, González Mendoza R, Roy A, Zhang Y, Gumuscu B, Cheng JD, Jin F, Rischin D; KEYNOTE-048 Investigators. Burtness B, et al. Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1. Lancet. 2019. PMID: 31679945 Clinical Trial.
COVID-19 Vaccine-Induced Radiation Recall Phenomenon.
Soyfer V, Gutfeld O, Shamai S, Schlocker A, Merimsky O. Soyfer V, et al. Among authors: gutfeld o. Int J Radiat Oncol Biol Phys. 2021 Jul 15;110(4):957-961. doi: 10.1016/j.ijrobp.2021.02.048. Epub 2021 Mar 4. Int J Radiat Oncol Biol Phys. 2021. PMID: 33677050 Free PMC article.
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.
Machiels JP, Tao Y, Licitra L, Burtness B, Tahara M, Rischin D, Alves G, Lima IPF, Hughes BGM, Pointreau Y, Aksoy S, Laban S, Greil R, Burian M, Hetnał M, Delord JP, Mesía R, Taberna M, Waldron JN, Simon C, Grégoire V, Harrington KJ, Swaby RF, Zhang Y, Gumuscu B, Bidadi B, Siu LL; KEYNOTE-412 Investigators. Machiels JP, et al. Lancet Oncol. 2024 May;25(5):572-587. doi: 10.1016/S1470-2045(24)00100-1. Epub 2024 Mar 29. Lancet Oncol. 2024. PMID: 38561010 Clinical Trial.
Elective Neck Dissection vs Observation in Early-Stage Squamous Cell Carcinoma of the Oral Tongue With No Clinically Apparent Lymph Node Metastasis in the Neck: A Systematic Review and Meta-analysis.
Abu-Ghanem S, Yehuda M, Carmel NN, Leshno M, Abergel A, Gutfeld O, Fliss DM. Abu-Ghanem S, et al. Among authors: gutfeld o. JAMA Otolaryngol Head Neck Surg. 2016 Sep 1;142(9):857-65. doi: 10.1001/jamaoto.2016.1281. JAMA Otolaryngol Head Neck Surg. 2016. PMID: 27442962 Review.
Extrapulmonary Small Cell Cancer: A New Insight into a Rare Disease.
Brazg Ferro L, Wolf I, Peleg Hasson S, Golomb I, Osher E, Berlin A, Gutfeld O, Ospovat I, Soyfer V. Brazg Ferro L, et al. Among authors: gutfeld o. Oncology. 2021;99(6):373-379. doi: 10.1159/000514520. Epub 2021 Mar 26. Oncology. 2021. PMID: 33774637
Diagnostic efficacy of positron emission computerized tomography scans in suspicious laryngeal findings postorgan preservation treatment.
Warshavsky A, Holan A, Muhanna N, Oestraicher Y, Nachalon Y, Kampel L, Nard-Carmel N, Chaushu H, Shapira U, Ungar O, Gutfeld O, Ospovat I, Oz YN, Even-Sapir E, Horowitz G. Warshavsky A, et al. Among authors: gutfeld o. Head Neck. 2023 Jan;45(1):207-211. doi: 10.1002/hed.27227. Epub 2022 Oct 27. Head Neck. 2023. PMID: 36301004
22 results